19 June 2013
Index pumps $11m into Cambridge spin-out
XO1, a spin-out from the University of Cambridge, raises $11m to form company to commercialise the “holy grail” of anticoagulant drugs.
Cambridge spin-out XO1, which is developing anticoagulants that could have a sizeable impact on preventing heart attacks and strokes, has received $11m from Index Ventures.
The life science investor was the sole participant in the $11m round, made through Index’s $200m Life Sciences fund launched last year, and represents the…Read More.
Supporting articles: Cambridge starts investing with Enterprise Fund / Cambridge aims for $2.2m / Cambridge breaks through the billion barrier / Cambridge’s Cronto sold for $22m / Cambridge’s new venture arm / AstraZeneca packs for Cambridge / Cambridge May deals hit quarter of a billion / Cambridge spin-out sees $29.1m on Horizon
19 June 2013
MSU names director
Richard W. Chylla (pictured) has been named executive director of Michigan State University’s (MSU) tech transfer office MSU Technologies.
Chylla joins MSU from the University of…
19 June 2013
Manchester’s spins flat out
UMI3, the commercialisation unit of the University of Manchester (UoM), has spun-out 2-D Tech, which will commercialise technology relating to “wonder material” graphene.
Graphene…
- 19 June 2013 – Yulex bounces $3m to Arizona
- 19 June 2013 – Hyde Park Angels spread wings
- 18 June 2013 – Kubisen joins George Washington
- 18 June 2013 – Sophia Genetics raises $2.8m
- 18 June 2013 – European universities sets up MiniNaviDent
